New drug shows promise for tough bladder cancer cases
NCT ID NCT04995419
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 32 times
Summary
This study tested a drug called enfortumab vedotin in 40 Chinese patients with advanced bladder cancer that had spread and stopped responding to chemotherapy and immunotherapy. The goal was to see if the drug could shrink tumors. The study measured tumor response, how long the effect lasted, and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site CN86001
Beijing, China
-
Site CN86002
Guangzhou, China
-
Site CN86003
Wuhan, China
-
Site CN86004
Shanghai, China
-
Site CN86006
Hangzhou, China
-
Site CN86007
Nanjing, China
-
Site CN86009
Changsha, China
Conditions
Explore the condition pages connected to this study.